Meridian Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$472K Buy
2,102
+89
+4% +$22.2K 0.02% 530
2025
Q4
$485K Buy
2,013
+103
+5% +$26.3K 0.02% 506
2025
Q3
$523K Buy
1,910
+394
+26% +$108K 0.02% 463
2025
Q2
$391K Buy
1,516
+163
+12% +$38.9K 0.02% 507
2025
Q1
$303K Buy
+1,353
New +$316K 0.01% 518

Other funds holding RMD

Meridian Wealth Management's RMD Position: Q1 2026 in Review

Meridian Wealth Management increased its ResMed (RMD) stake by 4.4% in Q1 2026, buying an estimated $22.2K and bringing the position to 2,102 shares worth $472K. The position accounts for 0.02% of the portfolio, ranked #530.

Meridian Wealth Management first reported a position in RMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $523K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Meridian Wealth Management held 2,102 shares of ResMed worth $472K as of Q1 2026.
  • Meridian Wealth Management bought 89 ResMed shares in Q1 2026, an estimated $22.2K.
  • ResMed made up 0.02% of Meridian Wealth Management's portfolio in Q1 2026, its #530 holding.
  • Meridian Wealth Management first reported a position in ResMed in Q1 2025 and has held it in 5 quarters since.
  • Meridian Wealth Management's ResMed position peaked at $523K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Meridian Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.